-
FutureGEN Girls Leadership Summit 2024: Empowering the Next Generation of Leaders
19 Dec 2024 06:49 GMT
… by our advertising partner.]
The FutureGEN Girls Leadership Summit 2024 brought … . Secy Cheung, Founding Board Director, FutureGen Girls Foundation; Panelists: Ms. Joanna …
-
Superpowers Unleashed: FutureGEN Girls Leadership Summit 2024 Inspires 300+ Teen Girls to "Act for Their Futures"
27 Nov 2024 11:03 GMT
… , alongside Mrs. Jennifer Yu Cheng, FutureGEN Girls Leadership Summit Organizing Committee … . Secy Cheung, Founding Board Director, FutureGen Girls Foundation, brought together a … Secy Cheung, Founding Board Director, FutureGen Girls Foundation, to unveil the …
-
Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal
24 Jun 2024 13:14 GMT
ClaudioVentrella Deals and Financings FutureGen Biopharm (Beijing) out-licensed global … clinically validated target in IBD. FutureGen believes the unique engineering of …
-
AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease
17 Jun 2024 11:46 GMT
North Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. … ., founder and chief executive officer, FutureGen Biopharmaceutical (Beijing) Co., Ltd. … currently in Phase 3. Additionally, FutureGen possesses several innovative multi-specific …
-
AbbVie to develop FutureGen’s IBD mAb in $150m deal
17 Jun 2024 12:47 GMT
… targeting TL1A.
According to FutureGen, FG-M701 is engineered with … to our collaboration with FutureGen in advancing development of … said Zhaoyu Jin, CEO, FutureGen.
“We believe that AbbVie … with AbbVie also highlights FutureGen's ability to …
-
AbbVie inks deal worth $1.56 B with China's FutureGen to develop IBD therapy
17 Jun 2024 11:40 GMT
… )
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a … , manufacture and commercialise FG-M701. FutureGen will receive $150 million in … , founder and chief executive officer, FutureGen Biopharmaceutical (Beijing) Co. said, …
-
AbbVie and FutureGen Partner on Inflammatory Bowel Disease Treatment
17 Jun 2024 09:38 GMT
… , manufacture and commercialize FG-M701. FutureGen will receive $150 million in … collaboration with AbbVie also highlights FutureGen's ability to generate … platform," said Zhaoyu Jin, FutureGen’s founder and CEO.
-
AbbVie, FutureGen enter license agreement to develop FG─M701, a next─generation TL1A antibody to treat inflammatory bowel disease
15 Jun 2024 06:40 GMT
… ., founder and chief executive officer, FutureGen Biopharmaceutical (Beijing) Co., Ltd. … manufacture and commercialize FG-M701. FutureGen will receive $150 million in … the medical challenges of tomorrow.
FutureGen Biopharmaceutical (Beijing) Co., Ltd. …
-
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
14 Jun 2024 09:06 GMT
… founder and chief executive officer, FutureGen Biopharmaceutical (Beijing) Co., Ltd. … formerly Twitter), and YouTube.
About FutureGen
FutureGen Biopharmaceutical (Beijing) Co., Ltd. … Phase 3. Additionally, FutureGen possesses several innovative multi-specific …
-
AbbVie and FutureGen link on inflammatory bowel disease
14 Jun 2024 14:07 GMT
… a licence agreement with FutureGen Biopharmaceutical to develop a … to our collaboration with FutureGen in advancing the … sales of the asset.
FutureGen Biopharmaceutical (Beijing) founder and … with AbbVie also highlights FutureGen’s ability to generate …
About
© 1995-2025